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SLC6A19The neutral amino acid transporter B°-like from rat kidney, previously reconstituted in liposomes, was
identiﬁed as B°AT1 by a speciﬁc antibody. Collectrin was present in the brush-border extract but not in
functionally active proteoliposomes, indicating that it was not required for the transport function. Neutral
amino acids behaved as competitive inhibitors of the glutamine transport mediated by B°AT1 with half
saturation constants ranging from 0.13 to 4.74 mM. The intraliposomal half saturation constant for glutamine
was 2.0 mM. By a bisubstrate kinetic analysis of the glutamine-Na+ cotransport, a random simultaneous
mechanism was found. Methylmercury and HgCl2 inhibited the transporter; the inhibition was reversed by
dithioerythritol, Cys and, at a lower extent, N-acetylcysteine but not by S-carboxymethylcysteine. The IC50 of
the transporter for methylmercury and HgCl2 was 1.88 and 1.75 μM, respectively. The reagents behaved as
non-competitive inhibitors toward both glutamine and Na+ and no protection by glutamine or Na+ was
found for the two inhibitors.ecyl ether; DTE, 1,4-dithioery-
boxymethylcysteine.
: +39 0984 492911
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B°AT1 is one of the mammalian amino acid transporters which
share the speciﬁcity for glutamine, thus being involved in the
absorption of glutamine in intestine, reabsorption in kidney and
transport in several other tissues. This transporter shows a broad
speciﬁcity for neutral amino acids with a preference toward amino
acids with hydrophobic residues. It has been identiﬁed in rat, human
and mouse [1–4]. B°AT1 corresponds to the transport system,
previously found in bovine renal epithelial cells, named B° [5]. This
transport system is highly expressed in kidney. Mutations of the
B°AT1 gene (SLC6A19) cause Hartnup disorder [2,6,7]. Most of the
functional knowledge of this transport system derives from studies
performed with cell systems overexpressing the transporter [2,3,8–
11]. Glutamine and the other neutral amino acids are co-transported
with sodium by an electrogenic mode. Na+ cannot be substituted by
Li+ and Cl− is not involved in the transport mechanism. The kinetic
mechanism of transport was reported to be of the simultaneous type
[3,8]. However some discrepancies are present between experimental
studies indicating an ordered simultaneous type of transport
mechanism [8] or a random type [3]. Indeed, the knowledge of theactual mechanism of transport represents the basis for understanding
the structure/function relationships of a membrane transport system.
Recently a transport system which shares all the basic functional
properties with B°AT1 has been reconstituted in liposomes by the
cyclic detergent removal procedure, which was previously success-
fully used for the reconstitution and functional studies of the ASCT2
and OCTN2 transporters [12–14]. The use of the proteoliposome
system gives the advantage of reducing the interferences by other
transporters or cell metabolism and improving the kinetic resolution
in respect to intact cell systems. The reconstituted transporter was
named B°-like [15]. The transporter was inserted in the proteolipo-
somes with the same orientation as in the cell membrane. Thus the
extraliposomal face corresponds to its extracellular face and vice
versa, the intraliposomal face corresponds to the intracellular one. The
studies in proteoliposomes revealed novel functional properties of
this transporter. It was shown that K+ modulates the B°-like activity
but is not transported. Optimal activity was found in the presence of
50 mM K+ in the intraliposomal (intracellular) compartment; at
higher concentration of K+ the transport activity decreased. The
transport is electrogenic due to the coupling of the amino acid ﬂux to
Na+, as it has been revealed through generation of a valinomycin-
induced K+ diffusion potential. The transporter is very sensitive to
hydrophilic mercurial SH reagents suggesting that Cys residues
exposed toward the extracellular space must be involved in the
transport function. In the present paper the reconstituted B°-like
transport activity is identiﬁed as the B°AT1 transporter. The transport
mechanism is clariﬁed and some novel kinetic properties are
described. In particular, the effect of mercuric compounds on the
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relevance since transport systems are located on the plasma
membrane of cells, thus being exposed to the action of exogenous
toxic compounds, such as methylmercury and HgCl2, which are the
main organic and inorganic forms of mercuric compounds contam-
inating the environment.
2. Materials and methods
2.1. Materials
Amberlite XAD-4, egg yolk phospholipids (3-sn-phosphatidylco-
line from egg yolk) C12E8 were purchased from Fluka; L-[3H]glutamine
from GE Healthcare; Sephadex G-75, from Sigma-Aldrich, antibody
against Angiotensin Converting Enzyme 2 (ACE2) from ABCAM,
antibody against Collectrin mAb (2G5) from ALEXIS, Goat Anti-Rabbit
IgG (H+L) Peroxidase Conjugated from PIERCE, Goat polyclonal
Secondary Antibody to Mouse IgG—H&L (HRP) from ABCAM.
Antibody against mouse B°AT1 was obtained as previously described
[16]. All other reagents were of analytical grade.
2.2. Solubilization of the B°AT1 transporter
Brush-border membranes were prepared from rat kidney and
stored as previously described [12,17]. The transporter was solubilized
by treating the membrane preparation (50 μl, about 0.2 mg protein)
with 1.3% C12E8, 20 mM Hepes/Tris pH 7.0 in a ﬁnal volume of 200 μl
and centrifuged at 13,000g for 4 min at 4 ° C. The supernatant (extract)
was used for the reconstitution.
2.3. Reconstitution of the B°AT1 transporter in liposomes
The B°AT1 transporter was reconstituted by the cyclic detergent
removal procedure [18,19] with appropriate modiﬁcations. In brief,
mixed micelles containing detergent, protein and phospholipids were
repeatedly passed through the same Amberlite XAD-4 column. The
composition of the initial mixture used for reconstitution was 15 μl of
the solubilized protein (about 10 μg protein in 1.3% C12E8), 80 μl of
10% C12E8, 100 μl of 10% egg yolk phospholipids in the form of
sonicated liposomes prepared as described in Ref. 18, 50 mM K-
gluconate and 20 mM Hepes/Tris pH 7.0 in a ﬁnal volume of 700 μl.
After vortexing, this mixture was passed 20 times through the same
Amberlite XAD-4 column (0.5 cm diameter×2.5 cm height) preequi-
librated with a buffer of the same composition as the initial mixture
but without the protein and the detergent. All operations were
performed at 4 °C, except the passages through Amberlite XAD-4,
which were carried out at room temperature.
2.4. Transport measurements
To remove the external buffer, 550 μl of proteoliposomes were
passed through a Sephadex G-75 column (0.7 cm diameter×15 cm
height) preequilibrated with 20 mM Hepes/Tris pH 7.0 and sucrose at
an appropriate concentration to balance the internal osmolarity.
Transport was started by adding 0.1 mM [3H]glutamine and 50 mM
Na-gluconate to the proteoliposomes, and stopped by adding 20 μM
mersalyl at the desired time interval. In control samples the inhibitor
was added at time zero according to the inhibitor stop method [20].
The control samples represent proteoliposome samples in which the
unspeciﬁc radioactivity, incorporated by diffusion or binding to the
membrane, is evaluated. The diffusion is not mediated by the
transporter, thus, can be measured when the transporter is inacti-
vated by mersalyl. This fraction of radioactive substrate also
corresponds to that found in liposomes without protein. The
unspeciﬁcally incorporated radioactivity is less than 5% of the [3H]glutamine speciﬁcally taken up by proteoliposomes, i.e., by trans-
porter mediated process.
The assay temperature was 25 °C. Finally, each sample of proteo-
liposomes (100 μl) was passed through a Sephadex G-75 column
(0.6 cm diameter×8 cm height) in order to separate the external from
the internal radioactivity. Liposomes were eluted with 1 mL 50 mM
NaCl and collected in 4 mL of scintillation mixture, vortexed and
counted. For the determination of the [3H]glutamine uptake, the
experimental values were corrected by subtracting the respective
controls (samples inhibited at time zero). Transport rate was measured
by stopping the reaction after 10 min, which is within the initial linear
range of labeled substrate uptake into the proteoliposomes.
For efﬂux measurements, aliquots of the same pool of proteolipo-
somes were incubated with external [3H]glutamine at different
concentrations and ﬁxed 50 mM Na-gluconate. After 30 min, corre-
sponding to the optimal intraliposomal [3H]glutamine accumulation,
the time course of [3H]glutamine efﬂux was measured. The efﬂux
reaction was stopped at the indicated time intervals by adding 20 μM
mersalyl. The efﬂux time course data were interpolated using a single
exponential decay equation from which the initial rates of the efﬂux
were calculated as the product of k (the ﬁrst order rate constant) and
the amount of [3H]glutamine efﬂuxed at inﬁnite time (equilibrium).
The concentration of internal [3H]glutamine at the beginning of the
efﬂux procedure was calculated as
nmol30min = nmol420minð Þ × glutamine½ ex
where: nmol30 min, nmoles of [3H]glutamine taken up at 30 min;
nmol420 min, residual nmoles of [3H]glutamine at the equilibrium
(420 min); [glutamine]ex, concentration of [3H]glutamine externally
added at time zero.
To generate a K+ diffusion potential, 50 mM K-gluconate was
added to the reconstitution mixture; K-gluconate was more efﬁcient
than other potassium salts, in activating the electrogenic process, as
previously described [15]. After removal of the external salts and
buffers by Sephadex G-75 chromatography, as described above, the
positive outside membrane potential was generated by adding
valinomycin (0.75 μg/mg phospholipid) in 3 μl ethanol/water 1:1
[21]. As previously found, the amount of ethanol added did not exert
any effect on the transport activity [15].
For the determination of the kinetic mechanism, the cotransport
velocity was analyzed as a function of both cosubstrate concentrations
(glutamine and Na+) in Lineweaver–Burk plots. The slope in these
plots equals the ratio Kmapp/Vmaxapp. Sequential and ping-pong
mechanisms can be discriminated by changing the concentrations of
the ﬁrst substrate. Depending on the mechanism different effects on
Vmaxapp/Kmapp values of the second substrate are observed. The
equation used is:
1= v =
1
Vmax
+ KG = Vmax⋅Gð Þ + KNa = Vmax⋅Nað Þ + KiG⋅KNa = Vmax⋅G⋅Nað Þ
where G, concentration of glutamine; Na, concentration of Na+; KiG ,
dissociation constant for the binary transporter–Gln complex; KG,
dissociation constant (Km) of Gln for the ternary transporter–Gln–Na+
complex; KNa, dissociation constant (Km) of Na+ for the ternary
transporter–Na+–Gln complex. KiNa, can be introduced by simply
transcribing the equation for Na+ as the variable substrate. In a random
sequential mechanism KiG KNa=KiNa KG; according to this equation, a
common intersection of the straight lines close to the x-axis for both the
co-substrates (no common intersection on the y-axis) is found [22–24].
2.5. Other methods
The homology structural model of B°AT1 was built by the Swiss-
Model protein modeling server [25] using the x-ray structure of the
Fig. 2. Sketch description of the experimental system of proteoliposome. The
membrane of the proteoliposome is represented by a ring. The B°AT1 transporter
and valinomycin (Vln) are inserted into the membrane. The ions Na+ and [3H]
glutamine are transported by B°AT1 from external to internal compartment, whereas
the K+ ion diffuses by means of valinomycin from the inside to outside compartment.
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molecular program SpdbViewer 4.01.The protein concentration was
determined by the modiﬁed Lowry procedure [27]. Proteins were
separated by SDS-PAGE on 12% polyacrylamide gels using the Hoefer
SE260 mini-vertical unit and stained by Coomassie-brillant blue R.
3. Results
3.1. Identiﬁcation of the B°AT1 transporter in the Brush Border extract
and in proteoliposomes
The presence of the B°AT1 transporter in the extract from puriﬁed
brush border was evaluated using a speciﬁc antibody against the
mouse B°AT1. This antibody cross-reacted with the rat protein as
expected by the sequence identity of 96% between the two proteins.
Since it was suggested that the B°AT1 transporter interacts with
collectrin and/or ACE2 [28–30,16], the presence of these proteins was
also detected with speciﬁc antibodies. As shown in Fig. 1A, a strong
immunoreactive band was observed in the brush-border extract with
the anti-B°AT1 (lane 3) and anti-collectrin (lane 2), whereas no
reaction was detected by the ACE2 (lane 1) antibody. The reactions
with anti-B°AT1 (lane 4) and anti-collectrin (lane 5) were also tested
in a protein extract obtained from solubilized proteoliposomes. A
strong immunoreactive band was observed, in this preparation, with
anti-B°AT1 only, indicating that collectrin was not associated with
liposomes. As shown in Fig. 1B the protein pattern associated with
proteoliposomes contained much less proteins than the brush border
extract. Indeed, most of the proteins were not incorporated or
associated to the liposomes, but were removed during the reconsti-
tution and during the passage through the Sephadex G-75 column.
The protein corresponding to the band at about 70 kDa was still
abundant in proteoliposomes, and its mass was very close to the
theoretical mass of rat B°AT1(71232 Da). The distortion of the protein
band was due to the high lipid content of the proteoliposome extract.
These data, together with the functional properties of the reconsti-
tuted transporter previously reported [15], indicated that the
reconstituted amino acid transport system is the B°AT1 transporter.
3.2. Kinetics
Fig. 2 shows a picture of the experimental system of proteolipo-
some. The B°AT1 transporter catalyses the cotransport of [3H]
glutamine with Na+ and valinomycin mediates the diffusion of K+
from inside to outside establishing a membrane potential positive
outside. The glutamine transport kinetics of the B°AT1 transporter
was studied in this system in the absence and presence of externallyFig. 1. Immunodetection of the rat B°AT1 transporter from kidney brush border. (A) lane
M: molecular mass markers: β-galactosidase (117 kDa), bovine serum albumin (85 kDa),
ovalbumin (48 kDa), carbonic anhydrase (34 kDa), β-lactoglobulin (26 kDa), lysozyme
(19 kDa). Diaminobenzidine immunodetection by anti-human ACE2 (lane 1), anti-mouse
collectrin (lane 2), anti-mouse B°AT1 (lane 3), on a PVDFmembrane blot of brush border
extract or of proteoliposome extract (B°AT1, lane 4; collectrin, lane 5). (B) SDS-PAGE of
the brush border protein (lane 1) or of proteoliposome (lane 2) extracts.added amino acids which were found to inhibit the transport [15]. As
shown in Fig. 3, the glutamine transport rate as a function of its
concentration gave a linear dependence in double (Lineweaver–Burk)
reciprocal plots. Purely competitive inhibition was found for methi-
onine, leucine, phenylalanine and, not shown, for the other amino
acids reported in Table 1, indicating that the amino acids bind to the
same site as glutamine. From the inhibition kinetic studies, the half
saturation constants Ki which correspond to Km value in case of
competitive inhibition, for the amino acids were derived (Table 1).
Lower half saturation constants (Ki), i.e., higher afﬁnity, were
observed for amino acids with hydrophobic side chains and for
tryptophan. The half saturation constant (Km) for glutamine derived
from the inhibition kinetic experiments was 0.55±0.10 mM and the
Vmax value 50.3±7.0 nmol/min/mg protein. The half saturation
constant for internal glutamine was calculated from [3H]glutamine
efﬂux. In this experiment separate pools of the same proteoliposome
preparation were incubated with different concentration of [3H]
glutamine. After accumulation of the labelled substrate, the time
course of [3H]glutamine efﬂux was measured (Fig. 4A) starting from
the experimental data at 30 min as described in Materials and
methods. From the data interpolated using a single exponential
decay equation the rate of efﬂux was determined and analyzed in
relation to the internal glutamine concentration using a double
reciprocal plot (Fig. 4B). From these data a half saturation constant for
internal glutamine of 2.01±0.4 mMwas derived. The Vmax calculated
from the efﬂux was 6.0±0.72 nmol/min/mg protein. It has to be
stressed that in the presence of intraliposomal Na+ at concentrationsFig. 3. Kinetic analysis of the inhibition of the reconstituted transporter by amino acids
at variable glutamine concentrations. Transport was measured by adding 50 mM Na-
gluconate containing [3H]glutamine at the indicated concentrations at time zero to
proteoliposomes containing 50 mM K-gluconate in the absence (○) of amino acids or in
the presence of 0.2 mM (●) methionine, (□) leucine or (■) phenylalanine. The
transport reaction was stopped after 10 min, as described in Materials and methods.
The experimental data were plotted according to Lineweaver–Burk as reciprocal
transport rate vs reciprocal glutamine concentrations. The values are means±S.D. from
three experiments.
Table 1
Half saturation constants of the reconstituted transporter
for neutral amino acids.
Amino acid Ki (mM)
Methionine 0.17±0.03
Leucine 0.13±0.05
Phenylalanine 0.23±0.05
Cysteine 0.19±0.05
Isoleucine 0.30±0.08
Valine 0.17±0.03
Alanine 0.47±0.01
Asparagine 1.11±0.16
Serine 1.26±0.14
Tryptophan 0.48±0.06
Threonine 1.90±0.48
Proline 4.74±1.32
Histidine 2.21±0.60
Glycine 3.11±0.42
Ki values were calculated from double reciprocal plots of
experimental data obtained by measuring [3H]glutamine
uptake at concentrations ranging from 0.13 to 0.5 mM in the
presence of external 50 mM Na-gluconate and internal
50 mM K-gluconate in the absence and presence of added
amino acids at the following concentration: Methionine,
Leucine, Phenylalanine, Valine, 0.2 mM; Isoleucine,
0.25 mM; Cysteine, Alanine, Tryptophan, 0.5 mM;
Asparagine and Serine, 1.2 mM; Threonine and Glycine,
2 mM; Proline and Histidine, 4 mM. The values are means
±S.D. from three experiments.
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(not shown). Under the experimental conditions described for Fig. 4,
the highest intraliposomal Na+ concentration was 12.2 mM, i.e., theFig. 4. Km of the transporter for glutamine on the internal side. (A), separate samples of
proteoliposomes containing 50 mM K-gluconate were preloaded by incubation with 5
(Δ), 1(■), 0.5 (□), 0.2 (●) or 0.1 (○) mM [3H]glutamine and 50 mM Na-gluconate.
After 30 min the time course of the efﬂux of labelled substrate was measured from each
sample. The initial rate of efﬂux was determined by interpolating the time course data
from 30 to 420 min in a ﬁrst order decay equation, as the product of k (ﬁrst order rate
constant) and the activity at 30 min. Similar results were obtained in three different
experiments which were used to calculate mean values of rates±S.D. plotted in (B)
according to Lineweaver–Burk as reciprocal transport rate vs reciprocal glutamine
concentrations.same as that of [3H]glutamine (seeMaterials andmethods), due to the
1:1 stoichiometry of Na+-glutamine preloading catalysed by the
B°AT1 transporter [15].
To obtain information on the kinetic mechanism of the glutamine
Na+ cotransport a bisubstrate kinetic analysis was performed. The
dependence of the cotransport rate on both external Na+ and
glutamine concentration was studied, in a single experiment. The
experimental data were plotted according to Lineweaver–Burk as a
function of the reciprocal glutamine (Fig. 5A) or the reciprocal Na+
(Fig. 5B) concentration. In both cases, an intersecting pattern of
straight lines was obtained with a common intersection point close to
the x-axis. This pattern indicates a simultaneous mechanism. This
mechanism can be differentiated in two different types: i) random,
which occurs when the two substrates do not have any preferential
order of binding to the transporter; ii) ordered, which occurs if one of
the substrates binds ﬁrst to the transporter. These two types can be
discriminated by double reciprocal (Lineweaver–Burk) plots. A
common intersection of the straight lines close to the x-axis for
both the cosubstrates indicates a random typemechanism. A common
intersection on the y-axis at least for one of the two cosubstrates
indicates an ordered type of mechanism. The kinetic analysis of the
B°AT1 transporter indicated a random type of mechanism. The
increase of the glutamine concentration led to a slight decrease of
the Km for Na+ and, vice versa, the increase of the Na+ concentration
led to a slight decrease of the Km for glutamine. By replotting the
apparent Vmax values derived from Fig. 5A and B (not shown), Km
values, which are independent from the counter substrate concen-
tration were derived. Their values were 0.62±0.15 mM for external
glutamine and 5.8±0.38 mM for external Na+.Fig. 5. Bi-substrate analysis of the glutamine–Na+cotransport mediated by the
reconstituted glutamine/amino acid transporter. Lineweaver–Burk plots showing the
dependence of glutamineex–Na+ex cotransport rate on external glutamine (A) or Na-
gluconate (B) concentrations. In (A) the concentrations of Na-gluconate were 6 (●),
8 (■), 13 (▲) and 25 (▼) mM. In (B) the concentrations of glutamine were 0.13 (●),
0.17 (■), 0.25 (▲) and 0.5 (▼) mM. The values are means±S.D. from three
experiments.
Fig. 7. Effect of cysteine, N-acetylcysteine and S-carboxymethylcysteine on the inhibition
of glutamine transport by mercuric reagents. After 1 min incubation with 3 μM HgCl2,
3 μM methylmercury or 6 μM mersalyl, 2 mM cysteine (Cys), N-acetylcysteine (NAC) or
S-carboxymethylcysteine (CMC) were added to the reconstituted proteoliposomes,
where indicated. After passage of the proteoliposomes through Sephadex G-75 columns
transport was measured by adding 0.1 mM [3H]glutamine and 50 mM Na-gluconate.
After 30 min the reaction was stopped, by adding 20 μM mersalyl.
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The effect of methylmercury on the B°AT1 transporter reconsti-
tuted in liposomes was investigated. Uptake of 0.1 mM [3H]glutamine
into proteoliposomes was measured in the absence or presence of
externally added mercuric reagents. The time courses of the
glutamine transport are shown in Fig. 6. As previously described
[15], the accumulation of labeled glutamine into the proteoliposomes
depended on the time. It reached a maximum of about 150 nmol/mg
protein and then decreased (○).The addition of 1 μMmethylmercury
together with the labelled substrate (□) caused strong inhibition of
transport of 69% at 20 min which became 67% at 60 min. The
experimental data were interpolated using a ﬁrst order rate equation.
The initial transport rate, calculated as the product of k and transport
at equilibrium, was 17.4±0.3 nmol min−1 mg protein−1 in absence
of reagents and 6.3±0.1 nmol min−1 mg protein−1 in the presence of
methylmercury. It is known that mercuric compounds react with Cys
residues of proteins forming an Hg―S bond [31]. To verify whether
the mercuric reagents reacted with Cys residues of the B°AT1
transporter, the effect of DTE, which reverses the Hg-S linkage, was
tested. The addition of DTE (■) after 10 min transport, to methyl-
mercury treated proteoliposomes, led to recovery of the transport
function, which was almost complete after 50 min from the addition
(60 min of transport). DTE had no similar activation effects in the
absence of mercuric reagents when added to control proteoliposomes
after 10 min (●). At 20 min of transport, DTE caused variations of
transport of−12.5±7.2% with respect to the samples in the absence
of DTE (in three different experiments). These variations were not
signiﬁcantly different from the control, without DTE, as estimated by
Student's t test (Pb0.05). Similar results were obtained with HgCl2
and mersalyl (not shown) in agreement with previous ﬁndings [15].
The experiments showed clearly that the inhibition was caused by
covalent interaction of the mercuric reagents with one (or more) SH
group of the protein. The effect of cysteine, N-acetylcysteine and S-
carboxymethylcysteine on the inhibition by mercuric reagents was
tested, as well (Fig. 7). After incubation of HgCl2 treated proteolipo-
somes with cysteine and N-acetylcysteine, 44% and 29% of the
uninhibited activity was recovered, respectively. In contrast, almost
no recovery was observed with S-carboxymethylcysteine. More
pronounced recoveries (more than 95% with Cys and more than 57%
with N-acetylcysteine) were observed in proteoliposomes pretreated
withmethylmercury andmersalyl. S-carboxymethylcysteine led to no
recovery after treatment with methylmercury and 47% recovery after
treatment with mersalyl (Fig. 7). The data conﬁrmed the involvement
of SH groups of the protein in the reaction. The dependence of the
reversal of the inhibition on the concentration of DTE, cysteine and N-Fig. 6. Effect of methylmercury on glutamine transport mediated by the reconstituted
transporter. Transport was measured by adding 0.1 mM [3H]glutamine and 50 mM Na-
gluconate in the presence of: (○) no additions; (□) 1 μM of methylmercury. After
15 min (●, ■) 2 mM DTE was added to an aliquot of the treated (□) and untreated (○)
reaction. The transport reaction was stopped at the indicated times, as described in
Materials and methods. The values are means±S.D. from three experiments.acetylcysteine was studied. Maximal effects were observed at
concentrations of the thiol containing reagents above 1 mM (not
shown).
3.4. Mechanism of inhibition of the transporter by mercuric reagents
The rate of glutamine uptake into proteoliposomes was deter-
mined in the presence of increasing concentration of mercuric
reagents. The dose–response curves obtained are shown in Fig. 8A.
The reagents led to a virtually complete inhibition at concentrationsFig. 8. Dose–response curves for the inhibition of the reconstituted transporter by
mercuric reagents. Transport was measured by adding 0.1 mM [3H]glutamine and
50 mM Na-gluconate to proteoliposomes (A) in the presence of HgCl2 (■) or
methylmercury (●) at the indicated concentrations. In (B) HgCl2 (■) or methylmercury
(●) at the indicated concentrations were added to the proteoliposomes before passage
through Sephadex G-75 columns and, then, the transport was started as described
above. In all the samples the transport reaction was stopped after 10 min by adding
20 μMmersalyl. Percent residual activity with respect to the control (76±13 nmol/mg
protein) is reported. The values are means±S.D. from three experiments.
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respectively. The IC50 values, derived from the dose–response curves,
were 0.42±0.03 μM and 0.89±0.04 μM for HgCl2 and methylmer-
cury, respectively. The values are close to that previously obtained for
mersalyl [15]. To conﬁrm that the inhibition of transport were caused
by covalent reaction of the mercuric reagents with the protein, the
residual activity of the transporter was determined after pre-
incubation of the proteoliposomes with the mercuric reagents and
subsequent removal of the unbound compounds. To achieve this
objective a strategy previously described for other transporters
[32,33] was adopted. After pre-incubation with each of the reagents,
the proteoliposomes were passed through size exclusion Sephadex G-
75 columns and, then, the transport activity was measured. The dose–
response curves obtained under this condition are reported in Fig. 8B.
Results similar to those of Fig. 8A were obtained. The calculated IC50
were 1.75±0.08 μM and 1.88±0.02 μM for HgCl2 and methylmer-
cury, respectively. These IC50 values were slightly higher than those
calculated for the same reagents added during the transport assay. To
obtain information on themechanism of inhibition, the dependence of
the transport rate on the extraliposomal glutamine or Na+ in the
absence or presence of methylmercury was studied. The data,
analyzed in double reciprocal (Lineweaver–Burk) plots (Fig. 9) were
interpolated by straight lines corresponding to the controls (without
reagents) or to different reagent concentrations, with common
intersections close to the x-axis. These patterns demonstrate non-
competitive inhibition with respect to both glutamine (Fig. 9A) andFig. 9. Kinetic analysis of the inhibition of the reconstituted transporter by
methylmercury at variable glutamine concentrations (A) and at variable Na+
concentrations (B). In (A) transport was measured by adding [3H]glutamine at the
indicated concentrations and 50 mM Na-gluconate at time zero to proteoliposomes
containing 50 mM K-gluconate in the absence (○) or in the presence of 1.2 μM (●) or
1.5 μM (□) methylmercury. In (B) transport was measured by adding 0.1 mM [3H]
glutamine and the indicated concentrations of Na-gluconate at time zero to
proteoliposomes containing 50 mM K-gluconate in the absence (○) or in the presence
of 1.2 μM (●) or 1.5 μM (□) methylmercury. The transport reaction was stopped after
10 min by adding 20 μM mersalyl. The experimental data were plotted according to
Lineweaver–Burk as reciprocal transport rate vs reciprocal glutamine concentrations
(A) or reciprocal Na-gluconate concentrations (B). The values are means±S.D. from
three experiments.Na+ (Fig. 9B). The half saturation constants of the transporter for the
inhibitor (Ki) were derived from the plots. The value of the Ki
calculated from Fig. 9 was 0.33±0.11 μM, similar to the IC50
determined in the transport assay. In the case of covalent inhibition
a non-competitive pattern does not provide unambiguous evidence
for separate substrate and inhibitor binding sites [34]. This can be
discriminated by protection experiments. If the active and inhibitory
sites overlap, the addition of the substrate before the inhibitor causes
a reduction of the inhibition. To clarify this point the proteoliposomes
were incubated with different concentrations of glutamine or Na+
before the addition of methylmercury. The concentration of the
reagent was kept relatively low (close to the IC50) to emphasize the
possible protection effect. The residual activity of the transporter in
the presence of methylmercury—38% (62% inhibition) of the control—
was virtually uninﬂuenced by the pre-incubation with the substrates,
independently of the concentrations used (Fig. 10A). In the presence
of Na+ a very slight protective effect could be observed up to 75 mM
Na+ which disappeared at higher concentrations. No protection by
substrate was found also in the case of HgCl2 (Fig. 10B).
4. Discussion
The glutamine transporter reconstituted in liposomes, previously
named B°-like, has been identiﬁed as the B°AT1 transporter by a
speciﬁc antibody. In agreement with previous ﬁndings [15], the B°AT1
transporter is highly abundant in the rat kidney brush-border
preparations used for the reconstitution. The proteoliposome extract
contained few protein bands, themost abundant of which showed theFig. 10. Inﬂuence of substrate on the inhibition of the reconstituted transporter by
mercuric reagents. Reconstituted proteoliposomes were treated as described in Fig. 8:
where indicated, glutamine or Na-gluconate at the concentrations (mM) in brackets
were added to proteoliposome samples 1 min before 2 μMmethylmercury (A) or 2 μM
HgCl2 (B). All samples were then passed through Sephadex G-75 columns to remove
excess inhibitor and substrates. Transport was started by adding 0.1 mM [3H]glutamine
and stopped after 30 min by adding 20 μM mersalyl. Percent residual activity with
respect to the control (128±17 nmol/mg protein) is reported. The values are means
±S.D. from three experiments.
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corresponding antibody. In the proteoliposome extract the intensity
of the B°AT1 band was very similar to that observed in the brush-
border extract in spite of the much lower total protein content,
demonstrating that the B°AT1 transporter was substantially puriﬁed
during the reconstitution procedure. The ﬁnding that collectrin, as
well as ACE2, is not required for transport function correlates well
with the proposed function of collectrin as regulator of transporter
expression [28–30]. However, on the basis of the experimental data
described in the present work, it cannot be ruled out that collectrin
may have some inﬂuence also on the intrinsic transport function of
B°AT1.
All amino acids tested were found to be competitive inhibitors of
glutamine transport, and as a result the Ki values are equivalent to the
Km values [35]. The data largely agree with previous observations in
cell systems [2,3]. In addition, the internal Km for glutamine could be
measured in the proteoliposome system. Its value was higher than the
external Km, whereas the Vmax value was lower than that measured on
the external side. This can be interpreted in terms of a functional
asymmetry of the transporter which correlates with the structural
asymmetry highlighted by the homology model of the rat B°AT1
(Fig. 11A), which is very similar to the human B°AT1 structural model
previously described [29] as it was expected by the high sequence
identity between the two proteins. However, it should be noted that
the [3H]glutamine efﬂux occurred in the absence of Na+ gradient
from inside to outside, which could explain the lower Vmax in the
efﬂux direction.
The transport mechanism studied using the proteoliposome
system was random simultaneous [22–24], conﬁrming previous data
obtained in intact cells [3]. A simultaneous mechanism with
preference of substrate binding order was also previously reported
[8], which does not correlate with our data. The discrepancy may be
due to interferences caused by other transporters or by the
intracellular metabolism in intact cell systems. We previously
reported that the B°AT1 transport system was strongly inhibited by
mercuric reagents [15]. This aspect has been further investigated
using methylmercury, the most common organic mercury form
present in the environment [36–39]. All the mercurials were very
effective in inhibiting the transport function of B°AT1. Interestingly
the inhibition by the inorganic and organic mercuric compounds was
nearly completely reversed by DTE and by the antioxidant N-
acetylcysteine. The data indicated that the mercuric compounds
react with Cys residues. The B°AT1 protein contains a CXXCmotif (Cys
200–Cys 203) which is known to be optimal binding site for heavyFig. 11. Homology structural model of rat B°AT1. (A) Ribbon diagram viewing the transpo
internal sides. (B) Membrane spanning domain of the protein containing the hypothetical s
residues are in dark gray. The homology structural model of B°AT1 was built as described inmetals and methylmercury [40]. This metal binding motif is located,
on the basis of the homology structural model of rat B°AT1(Fig. 11B),
close to the membrane and far from the hypothesized substrate
binding site. This correlates well with the non-competitive inhibition
and the lack of substrate protection found for methylmercury and
HgCl2. On the contrary, substrate protection of the inhibition by
mersalyl of the B°AT1 transporter [15] was found previously, which
indicated the vicinity of the reaction site of mersalyl and the substrate
binding site, or, alternatively the induction of conformational changes
of the substrate binding site induced by substrate binding that limits
the reactivity of the inhibitor. Furthermore S-carboxymethylcysteine
partially reversed the inhibition by mersalyl, differently from HgCl2
and methylmercury. The different behavior indicates that the site for
mersalyl binding is different from the site for methylmercury binding.
This correlates well with the different chemical features of the two
reagents, i.e., mersalyl is hydrophilic whereas methylmercury is
hydrophobic. A possible site of interaction of the more hydrophilic
reagent mersalyl might be constituted by Cys-45 or Cys-49, which are
close to the substrate binding site of B°AT1 (Fig. 11B) predicted on the
basis of the human B°AT1 homology structure [29]. However, other
Cys residues, out of the 4 hypothesized, could not be excluded as
possible site of mercuric reagent target.
The inhibition of the transport function upon reaction of the
mercuric reagents with the Cys residue(s) may be caused by
impairment of mobility of the hydrophilic loops and/or other domains
of the transporter, which is necessary for the transport cycle.
The implication of the mechanisms of inhibition of the B°AT1
transporter in toxicology may be relevant since this transport system
plays important functions in several districts among which the
intestine and kidney [4]. Mercuric reagents are known to inhibit
renal transport at concentrations far below the LD50 [41]. Thus, the
inactivation of the B°AT1 transportermay impair the permeability and
the metabolism of tissues and organs in which it is expressed, under
conditions in which the mercuric compounds are still below the level
of acute toxicity. Methylmercury is readily absorbed by the intestine
and reaches concentration of 1–8 μg/L in the blood of normal people.
Above 200 μg/L (about 1 μM), methylmercury exerts toxic effects [37].
The IC50 of the transporter for this reagent is in the same range of the
toxicity threshold. At the renal or intestinal level the inactivation of
B°AT1 may impair the adsorption of neutral amino acid. Other
transporters have been reported to interact with methylmercury with
afﬁnity in the range of the toxicity threshold of this compound. These
transporters, such as ASCT2 [40], Lat1 [42], B°,+ [38] should be
involved as B°AT1 in the mercurial toxicity. The effects of cysteine andrter from the lateral side; the membrane is indicated by black lines with external and
ubstrate binding site indicated by a dotted circle. Cys-45, Cys-49, Cys-200 and Cys-203
Materials and methods and represented using the molecular program SpdbViewer 4.01.
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well with the use of these antioxidant compounds in mercury
detoxiﬁcation [36].
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